DNA ligase IV is a potential molecular target in ACNU sensitivity

Cancer Science

Volumn 101, Issue 8, 2010, Pages 1881-1885

  Kondo, Natsuko ^a,c   Takahashi, Akihisa ^a   Mori, Eiichiro ^a   Noda, Taichi ^a   Su, Xiaoming ^a   Ohnishi, Ken ^a   McKinnon, Peter J ^b   Sakaki, Toshisuke ^a   Nakase, Hiroyuki ^a   Ono, Koji ^c   Ohnishi, Takeo ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NIMUSTINE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE IV; RAD54 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; COLONY FORMING UNIT; CONTROLLED STUDY; DNA CROSS LINKING; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; FIBROBLAST; GENE SILENCING; GLIOBLASTOMA; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; LETHALITY; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TARGETED GENE REPAIR; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; DNA BREAKS, DOUBLE-STRANDED; DNA LIGASES; DNA REPAIR; GLIOBLASTOMA; HUMANS; MICE; NIMUSTINE; NUCLEAR PROTEINS;

EID: 77954858156     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01591.x     Document Type: Article

References (28)

1. Stupp R, Mason WP, van den Bent MJ. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-96.
2. Wolff JE, Berrak S, Koontz Webb SE. Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients. J Neurooncol 2008, 88:57-63.
3. Gonzaga PE, Potter PM, Niu TQ. Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA. Cancer Res 1992, 52:6052-8.
4. Kokkinakis DM, Bocangel DB, Schold SC, Moschel RC, Pegg AE. Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. Clin Cancer Res 2001, 7:421-8.
5. Bobola MS, Berger MS, Silber JR. Contribution of O6-methylguanine-DNA methyltransferase to resistance to 1,3-(2-chloroethyl)-1-nitrosourea in human brain tumor derived cell lines. Mol Carcinog 1995, 13:81-8.
6. Kaina B, Christmann M, Naumann S, Roos WP. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst) 2007, 6:1079-99.
7. Preuss I, Eberhagen I, Haas S. O6-methylguanine-DNA methyltransferase activity in breast and brain tumors. Int J Cancer 1995, 61:321-6.
8. Lees NP, Harrison KL, Hill E, Hall CN, Povey AC, Margison GP. Heterogeneity of O6-alkylguanine-DNA alkyltransferase activity in colorectal cancer: implications for treatment. Oncology 2002, 63:393-7.
9. Batista LF, Roos WP, Christmann M, Menck CF, Kaina B. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks. Cancer Res 2007, 67:11886-95.
10. Ohnishi T, Mori E, Takahashi A. DNA double-strand breaks: Their production, recognition, and repair in eukaryotes. Mutat Res 2009, 669:8-12.
11. Takahashi A, Matsumoto H, Nagayama K. Evidence for the involvement of double-strand breaks in heat-induced cell killing. Cancer Res 2004, 64:8839-45.
12. Kondo N, Takahashi A, Mori E. DNA ligase IV as a new molecular target for temozolomide. Biochem Biophys Res Commun 2009, 387:656-60.
13. Tsaryk R, Fabian K, Thacker J, Kaina B. Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide. Cancer Lett 2006, 239:305-13.
14. Nojima K, Hochegger H, Saberi A. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res 2005, 65:11704-11.
15. Margison GP, Santibañez-Koref MF. O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. Bioessays 2002, 24:255-66.
16. McHugh PJ, Spanswick VJ, Hartley JA. Repair of DNA interstrand cross-links: molecular mechanisms and clinical relevance. Lancet Oncol 2001, 2:483-90.
17. Donahue SL, Lundberg R, Saplis R, Campbell C. Deficient regulation of DNA double-strand break repair in Fanconi anemia fibroblasts. J Biol Chem 2003, 278:29487-95.
18. Shim KS, Schmutte C, Tombline G, Heinen CD, Fishel R. hXRCC2 enhances ADP/ATP processing and strand exchange by hRAD51. J Biol Chem 2004, 279:30385-94.
19. Tan TL, Essers J, Citterio E. Mouse Rad54 affects DNA conformation and DNA-damage-induced Rad51 foci formation. Curr Biol 1999, 9:325-8.
20. Weterings E, van Gent DC. The mechanism of non-homologous end-joining: a synopsis of synapsis. DNA Repair (Amst) 2004, 3:1425-35.
21. Thode S, Schafer A, Pfeiffer P, Vielmetter W. A novel pathway of DNA end-to-end joining. Cell 1990, 60:921-8.
22. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998, 273:5858-68.
23. Takahashi A, Ohnishi T. Does γH2AX foci formation depend on the presence of DNA double strand breaks? Cancer Lett 2005, 229:171-9.
24. Ward IM, Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem 2001, 276:47759-62.
25. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000, 10:886-95.
26. Takahashi A, Yamakawa N, Kirita T. DNA damage recognition proteins localize along heavy ion induced tracks in the cell nucleus. J Radiat Res (Tokyo) 2008, 49:645-52.
27. Bessho T. Induction of DNA replication-mediated double strand breaks by psoralen DNA interstrand cross-links. J Biol Chem 2003, 278:5250-4.
28. Hermisson M, Klumpp A, Wick W. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem 2006, 96:766-76.